APA (7th ed.) Citation

Ziemssen, T., Schlegel, E., Groth, M., Ettle, B., & Bopp, T. (2023). Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis. MDPI AG.

Chicago Style (17th ed.) Citation

Ziemssen, Tjalf, Eugen Schlegel, Marie Groth, Benjamin Ettle, and Tobias Bopp. Results on SARS-CoV-2 MRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis. MDPI AG, 2023.

MLA (9th ed.) Citation

Ziemssen, Tjalf, et al. Results on SARS-CoV-2 MRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis. MDPI AG, 2023.